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insight into a transcriptional activator and
an important step forward as we continue
to decipher the underpinnings of gene
regulation in malaria parasites.
Beyond the importance of these find-
ings for shedding light on mechanisms
of gene regulation in Plasmodium, the
characterization of regulatory pathways
dependent on bromodomain proteins
has potential for developing novel thera-
peutic strategies. Inhibitors of bromodo-
mains have recently been described that
can drastically alter gene expression in
treated cells, highlighting the potential
for this class of inhibitors (Filippakopoulos
and Knapp, 2014). In the case of PfBDP1,
inhibition would substantially reduce or
eliminate the parasite’s ability to invade
red blood cells, thus terminating the
infection. It is likely that the remaining
members of the bromodomain family in
P. falciparum have similarly important
roles in regulating parasite growth and
replication. Further work on this family
and other key regulatory proteins will
open additional avenues for potential ma-
laria-intervention strategies.
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Although bacteria have long been associatedwith human cancer, drawing causal relationships has been diffi-
cult. In this issue of Cell Host & Microbe, Scanu et al. (2015) provide evidence for a transforming activity of
Salmonella Typhimurium on predisposed host cells, which can subsequently form tumors in a xenograft
model.
Infectious agents are increasingly being
recognized as risk factors for human
cancers. Current estimates assume that
some 15–20 percent of human cancers
are caused by infections, mostly viruses,
but also bacteria and even parasites.
Recognition of such infection-cancer rela-
tionships is of utmost importance since it
provides the basis for establishing appro-
priate precautions, including the genera-
tion of cancer-preventing vaccines or the
prophylactic use of antibiotics.
Evidence for the involvement of bacte-
ria in initiating or promoting human can-
cers is still indirect and mainly based
on epidemiological associations. This is
even true for the bacterium Helicobacter
pylori, which is widely accepted to induce
Table 1. List of Bromodomain-Containing Proteins Encoded in the Genome of the Malaria Parasite Plasmodium falciparum
Protein Name PfID (Previous ID) Proposed Function References
PfBDP1 PF3D7_1033700 (PF10_0328) Coordinates expression of genes involved in red blood cell invasion Josling et al., 2015
PfBDP2 PF3D7_1212900 (PFL0635c) Found to associate with PfBDP1 Josling et al., 2015
PfSET1 PF3D7_0629700 (PFF1440w) Histone methyltransferase involved in the deposition of the epigenetic
mark H3K4me3, also contains bromodomain
Cui et al., 2008
PfGCN5 PF3D7_0823300 (PF08_0034) Histone acetyltransferase, found to associate with the transcriptional
coactivator PfADA2
Fan et al., 2004
– PF3D7_1475600 (PF14_0724) Unknown function –
– PF3D7_0110500 (PFA0510W) Unknown function –
– PF3D7_1234100 (PFL1645w) Unknown function –
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cancer and held responsible for roughly
70 percent of all gastric malignancies.
However, recent mechanistic insights
into the cellular responses to infection—
nurtured by observations from experi-
mental mouse models—lend increasing
support for a direct role of bacterial path-
ogens in the causality of human cancers.
Notably, while the role of inflammation
in carcinogenesis has been established,
there has been little effort to extrapolate
this to the question of what the triggers
of such inflammatory processes are.
Clearly, bacterial infections are a signifi-
cant driver of inflammation. It has there-
fore become a burning question to iden-
tify which bacteria are able to directly
contribute to carcinogenesis and if there
are other mechanisms apart from inflam-
mation by which such pathogens drive
host cells into cancerous conditions.
To delineate causal relationships be-
tween an infection and cancer onset is
difficult, mainly because of the long time
span between the two events. Conclusive
connections to cancers could only be
drawn for certain viruses, based on the
deposition of viral transforming genes in
the affected host. Handicapped by the
lack of such genetic marks, researchers
have begun to translate the complexity
of bacteria-driven carcinogenesis to cell
culture models in order to recapitulate
aspects of the long-term transformation
process in vitro. Assuming the principal
validity of short-term infection studies,
researchers build upon the hypothesis
that cancer initiation in vivo is likely
to be a frequent event, though kept
tightly in check by cell- and tissue-
intrinsic as well as immune surveillance
mechanisms.
Such in vitro studies require non-trans-
formed or at least non-malignant cells as
experimental models to work with, as
well as suitable read-out systems indica-
tive of malignancy, including growth fac-
tor independence, apoptosis resistance,
cellular invasiveness, anchorage-inde-
pendent growth, and ultimately tumor
formation in xenograft models. Interest-
ingly, signs of in vitro transformation
have been obtained by chronically infect-
ing cells with Propionibacterium acnes
(Fassi Fehri et al., 2011). Over time, tu-
mor-like cell populations arose that ex-
hibited transformed features, such as
anchorage-independence and increased
STAT3 signaling.
In this current issue of Cell Host &
Microbe, Scanu et al. (2015) provide
another example of in vitro transforma-
tion by infecting mouse cells with Salmo-
nella Typhimurium, followed by a direct
demonstration of the emergence of trans-
formed cells capable of forming tumors in
a mouse xenograft model.
Indeed, there is a strong epidemiolog-
ical link between Salmonella and human
gallbladder cancer. Salmonella Typhi
causes systemic infections in humans,
and the infection can spread to various
organs including the gallbladder, where
in rare cases it can persist to consti-
tute a chronic carrier state, generally
associated with chronic inflammation
and a higher risk of developing gall-
bladder cancer. Following these pre-
mises, the team headed by Jacques
Neefjes observed an interesting differ-
ence in gallbladder cancer samples
from Indian and European patients: while
both cancer groups expressed a mutant
form of the tumor suppressor P53, most
of the Indian samples also showed
an overexpression of the oncogene
c-MYC, which correlates with a higher
prevalence of S. Typhi in the serum of
these patients.
Scanu et al. (2015) were now able to
model the link between Salmonella and
human cancer inmice. Since upregulation
of c-MYC occurs under activation of the
Wnt pathway, they infected genetically
modified mice (Apc+/min) with S. Typhimu-
rium and observed the appearance of
colorectal adenocarcinomas approxi-
mately one year post-infection. This result
corroborates the potential of the Apc+/min
mutation to drive bacteria-induced carci-
nogenesis, which was previously ob-
served in the colon after infection
with Fusobacterium nucleatum and Citro-
bacter rodentium (Kostic et al., 2013;
Newman et al., 2001). Similarly, other
bacteria such as H. pylori, Helicobacter
hepaticus, and pathogenic strains of
Escherichia coli are able to induce tumors
in mice with other genetic predisposi-
tions. However, the present paper also
successfully demonstrates that Salmo-
nella acts as a transforming agent
in vitro. Accordingly, transformation
occurred in the absence of immune cells
in a process driven by just two determi-
nants, the microbe and the infected cell.
For this purpose, the authors used
genetically altered mouse embryonic fi-
broblasts that lack functional P53 and
overexpress c-MYC, representing a con-
dition bordering on malignancy. How-
ever, the conversion into cells capable
of anchorage-independent colony forma-
tion in soft agar was clearly dependent
on infection with either S. Typhimurium
or S. Typhi, and the injection of bacterial
effectors appeared to be a driving force
of sustained mitotic activity. Interestingly,
only a few hours of exposure to Salmo-
nella followed by antibiotic treatment
was enough to induce colony growth in
soft agar, and the transformed status
persisted even in the absence of the bac-
teria. The resulting cells continued to rely
on AKT and MAP kinase pathway activa-
tion and induced tumors when grafted
into immune-deficient mice. This signifies
an irreversible transformation process,
although it is still unclear how Salmonella
leads to sustained constitutive activation
of AKT and MAP kinase pathways even
after it is eradicated.
Since cancer is a genetic disease, so-
matic mutations (or heritable epigenetic
alterations) coupled with micro-environ-
mental selection are the driving force
during each step of carcinogenesis. Sal-
monella also has mutational potential in
that it secretes the cytolethal distending
toxin (CDT), which reaches the nucleus
of target cells via the endocytic route.
However, only the serovar Typhi, not
Typhimurium, encodes the genes for
secretion of the toxin, and it is hence inter-
esting to note that Scanu et al. obtained
similar results with either strain. In their
experiment, the lack of P53, known as
the guardian of the genome, might
possibly have led to an uncontrolled
accumulation of spontaneous mutations.
Interestingly, it has been shown that
exposure of cells to CDT alone is enough
to induce anchorage-independent growth
of rat fibroblasts (Guidi et al., 2013). This
toxin promotes genome instability with
accumulation of chromatin and chromo-
somal aberrations. Other bacteria such
as H. pylori, Neisseria gonorrhoeae, and
Chlamydia trachomatis can also induce
DNA damage combined with an altered
DNA damage response (Koeppel et al.,
2015; Vielfort et al., 2013) and an induc-
tion of survival and growth (Chumduri
et al., 2013). Moreover, gallbladder infec-
tions with S. Typhi may give rise to muta-
genic metabolites. Although still specula-
tive, it seems plausible that Salmonella,
Cell Host & Microbe 17, June 10, 2015 ª2015 Elsevier Inc. 729
Cell Host & Microbe
Previews
too, might drive carcinogen-
esis via a two-fold route, i.e.,
by inducing heritable changes
(mutations as well as epige-
netic changes) and their
manifestation by exerting
pro-survival signals on the in-
fected cell (Figure 1).
Recent progress in the
cultivation of epithelial cells,
the prime target of mucosal
infections and the source of
carcinomas, now has the
potential to substantially
advance our understanding
of how pathogens might stim-
ulate cancer initiation in real
life. The use of normal,
healthy, human 3D cultures
called organoids, instead of
cell lines or primary fibro-
blasts, to model bacterial
oncogenesis has substantial
advantages. By introducing
sequential mutations, for
example, it has recently
been possible to simulate
mutational scenarios of can-
cer progression (Drost et al.,
2015). In the work done by
Scanu and colleagues, gall-
bladder organoids were
derived from mutant mice with inactive
P53 and infected with Salmonella. In
contrast to the non-infected organoids,
the infected ones were able to grow in
the absence of specific supplements. In
another recent publication, gastric orga-
noids were used to model H. pylori
involvement in gastric cancer, showing
that infected organoids acquire a
hyperproliferative phenotype that is
dependent on CD44 (Bertaux-Skeirik
et al., 2015).
These experiments belong to the
first but still tentative attempts to model
bacterial carcinogenesis in organoids.
Whether bacteria can transform the
primary epithelial cells in organoids is
still an open question, and suitable
assays prior to testing transformation
in a mouse xenograft model will need
to be developed. Altogether, these
new findings highlight the anticipated
link between bacterial infections and
human cancer, rendering microbial
carcinogenesis one of the most chal-
lenging and medically important areas
at the forefront of infectious disease
research.
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Figure 1. DNA Damage and Cell-Activating Pathways Cooperate in
Driving Malignant Transformation by Bacterial Pathogens
Previous work suggests a secreted genotoxin (CDT) together with mutagenic
metabolites as the main source of Salmonella’s carcinogenic potential, which
may culminate in cancer of the human gallbladder. However, intoxicated cells
are prone to die unless Salmonella stimulates damaged cells to survive. Scanu
et al. (2015) stimulated the transformation of genetically predisposed murine
fibroblasts (P53Y, c-MYC[) by infecting them with Salmonella in vitro, which
led to a constitutive activation of the AKT and MAPK survival pathways.
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